Donald Trump
Donald Trump The White House, Public domain, via Wikimedia Commons

President Donald Trump attended a Medal of Honour ceremony in the White House East Room on 2 March 2026, where he presented awards to three US Army service members. The event was held to recognise the service and sacrifice of military personnel, including actions taken during past conflicts.

During the public appearance, observers noted a visible area of skin irritation on the right side of the president's neck. Photographs taken during the ceremony, which were published by various media organisations, showed redness extending above the president's shirt collar.

Following public and media interest regarding the visible mark, Dr Sean Barbabella, the president's personal physician, issued a statement on Monday clarifying the nature of the condition. He characterised the irritation as a side effect of a routine medical regimen.

Official Explanation of Medical Treatment

Dr Barbabella confirmed that the irritation is a side effect of a prescribed topical treatment. In a statement released to media outlets, he addressed the visible skin condition directly to provide clarity on the matter.

'President Trump is using a very common cream on the right side of his neck, which is a preventative skin treatment, prescribed by the White House Doctor,' Dr Barbabella stated. 'The president is using this treatment for one week, and the redness is expected to last for a few weeks.'

While the administration has identified the usage of a preventative cream, it has not disclosed the commercial name of the product or the specific dermatological condition it is intended to address. This response follows established medical protocols for the president, often referencing prior documentation to contextualise current care.

Previous Medical Disclosures and Context

Public records indicate that the president's medical team has previously addressed his dermatological health. A memorandum released by the White House physician on 13 April 2025, following the president's annual physical examination, identified specific ongoing treatments.

The memorandum explicitly noted that the president uses mometasone cream 'as needed' for an unspecified skin condition. Mometasone is a potent corticosteroid typically prescribed to reduce inflammation, itching, and swelling. The April 2025 document noted that the skin examination revealed some minor sun damage and a few benign lesions, though it confirmed that no concerning growths were identified at that time.

Expert Commentary and Public Debate

The recent appearance of the irritation has prompted commentary from various medical analysts regarding the administration's disclosure practices. Dr Vin Gupta, a medical analyst, expressed criticism regarding the administration's communication style, suggesting that acknowledging specific skin conditions could prevent public speculation.

Similarly, Dr Jonathan Reiner, a cardiologist, noted that while preventative skin treatments are common for individuals with dermatological concerns, the lack of clarity regarding the specific nature of the president's treatment creates ambiguity. Dr Reiner also remarked on the phrasing of the physician's statement, noting that the reference to the White House Doctor as a distinct entity from the physician issuing the statement was atypical.

Wider Context of Presidential Health

The focus on the president's neck irritation is part of a wider, ongoing public interest in the health of the oldest-serving president. Throughout his current term, the administration has periodically addressed observations made by the public and media regarding physical markers of health.

The White House maintains that the president remains in excellent overall health, a conclusion supported by medical screenings conducted at the Walter Reed National Military Medical Center late last year. As of now, the administration has provided no further details on the specific nature of the skin treatment or the president's ongoing health plan, maintaining that the condition is minor and part of routine care.